Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro

Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro

With over 50 million currently confirmed cases worldwide, including more than 1.3 million deaths, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a major impact on the economy and health care system. Currently, limited prophylactic or therapeutic intervention options ar...

Full description

Bibliographic Details
Main Authors: Melle Holwerda, Philip V’kovski, Manon Wider, Volker Thiel, Ronald Dijkman
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Microorganisms
Subjects:
pandemic response box
drug repurposing
compound screen
SARS-CoV-2
Retro-2.1
remdesivir
Online Access:https://www.mdpi.com/2076-2607/8/12/1872

Internet

https://www.mdpi.com/2076-2607/8/12/1872

Similar Items